<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Membrane Transporter Database for Personalized Medicine &#187; Diseases</title>
	<atom:link href="http://pharmtao.com/blog5/index.php/category/transporter-disease/feed/" rel="self" type="application/rss+xml" />
	<link>http://pharmtao.com/blog5</link>
	<description>Databases and Encyclopedia of Transporters, Translational Medicine, Drug Discovery and Development</description>
	<lastBuildDate>Sat, 03 Apr 2010 00:42:11 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>Diseases: Obesity: Related Transporters: UCP1  (uncoupling protein 1 (mitochondrial, proton carrier)) &#8211; UCP3  (uncoupling protein 3 (mitochondrial, proton carrier))</title>
		<link>http://pharmtao.com/blog5/2010/04/02/diseases-obesity-related-transporters-ucp1-uncoupling-protein-1-mitochondrial-proton-carrier-ucp3-uncoupling-protein-3-mitochondrial-proton-carrier/</link>
		<comments>http://pharmtao.com/blog5/2010/04/02/diseases-obesity-related-transporters-ucp1-uncoupling-protein-1-mitochondrial-proton-carrier-ucp3-uncoupling-protein-3-mitochondrial-proton-carrier/#comments</comments>
		<pubDate>Sat, 03 Apr 2010 00:42:11 +0000</pubDate>
		<dc:creator>PharmTao.com</dc:creator>
				<category><![CDATA[Obesity]]></category>
		<category><![CDATA[Diseases]]></category>
		<category><![CDATA[Mitochondrial]]></category>
		<category><![CDATA[proton carrier]]></category>
		<category><![CDATA[Related]]></category>
		<category><![CDATA[Transporters]]></category>
		<category><![CDATA[UCP1]]></category>
		<category><![CDATA[UCP3]]></category>
		<category><![CDATA[uncoupling protein 1]]></category>

		<guid isPermaLink="false">http://pharmtao.com/blog5/?p=134</guid>
		<description><![CDATA[
UCP1 (uncoupling protein 1 (mitochondrial, proton carrier))

<p> </p>
<p>Other Symbols: </p>
<p>SLC25A7, UCP</p>
<p>Disease relevance:</p>
<p>UCP1 -3826G allele has been found to be associated with obesity with a gender-related effect (Ramis et al., 2004).</p>
<p>References:</p>
<p>Ramis JM, González-Sánchez JL, Proenza AM, Martínez-Larrad MT, Fernández-Pérez C, Palou A, Serrano-Ríos M. The Arg64 allele of the beta 3-adrenoceptor gene but not the -3826G [...]]]></description>
		<wfw:commentRss>http://pharmtao.com/blog5/2010/04/02/diseases-obesity-related-transporters-ucp1-uncoupling-protein-1-mitochondrial-proton-carrier-ucp3-uncoupling-protein-3-mitochondrial-proton-carrier/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diseases: Obesity: Related Transporters: CETP  (cholesteryl ester transfer protein, plasma) &#8211; SLC6A4  (solute carrier family 6 (neurotransmitter transporter, serotonin), member 4)</title>
		<link>http://pharmtao.com/blog5/2010/04/01/diseases-obesity-related-transporters-cetp-cholesteryl-ester-transfer-protein-plasma-slc6a4-solute-carrier-family-6-neurotransmitter-transporter-serotonin-member-4/</link>
		<comments>http://pharmtao.com/blog5/2010/04/01/diseases-obesity-related-transporters-cetp-cholesteryl-ester-transfer-protein-plasma-slc6a4-solute-carrier-family-6-neurotransmitter-transporter-serotonin-member-4/#comments</comments>
		<pubDate>Fri, 02 Apr 2010 01:12:23 +0000</pubDate>
		<dc:creator>PharmTao.com</dc:creator>
				<category><![CDATA[Obesity]]></category>
		<category><![CDATA[CETP]]></category>
		<category><![CDATA[cholesteryl ester transfer protein]]></category>
		<category><![CDATA[database]]></category>
		<category><![CDATA[Diseases]]></category>
		<category><![CDATA[member 4]]></category>
		<category><![CDATA[neurotransmitter transporter]]></category>
		<category><![CDATA[plasma]]></category>
		<category><![CDATA[Related Transporters]]></category>
		<category><![CDATA[serotonin]]></category>
		<category><![CDATA[SLC6A4]]></category>
		<category><![CDATA[solute carrier family 6]]></category>

		<guid isPermaLink="false">http://pharmtao.com/blog5/?p=132</guid>
		<description><![CDATA[
CETP (cholesteryl ester transfer protein, plasma)

<p> </p>
<p>[HDLCQ10]</p>
<p>In diabetic obesity, CETP may have an antiatherogenic effect (MacLean et al., 2003).</p>
<p>References:</p>
<p>MacLean PS, Bower JF, Vadlamudi S, Osborne JN, Bradfield JF, Burden HW, Bensch WH, Kauffman RF, Barakat HA. Cholesteryl ester transfer protein expression prevents diet-induced atherosclerotic lesions in male db/db mice. Arterioscler Thromb Vasc Biol. 2003 Aug [...]]]></description>
		<wfw:commentRss>http://pharmtao.com/blog5/2010/04/01/diseases-obesity-related-transporters-cetp-cholesteryl-ester-transfer-protein-plasma-slc6a4-solute-carrier-family-6-neurotransmitter-transporter-serotonin-member-4/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diseases: Obesity: AQP9  (aquaporin 9)</title>
		<link>http://pharmtao.com/blog5/2010/03/25/diseases-obesity-aqp9-aquaporin-9/</link>
		<comments>http://pharmtao.com/blog5/2010/03/25/diseases-obesity-aqp9-aquaporin-9/#comments</comments>
		<pubDate>Fri, 26 Mar 2010 05:09:51 +0000</pubDate>
		<dc:creator>PharmTao.com</dc:creator>
				<category><![CDATA[Obesity]]></category>
		<category><![CDATA[adipocytes]]></category>
		<category><![CDATA[AQP9]]></category>
		<category><![CDATA[aquaporin 9]]></category>
		<category><![CDATA[Diseases]]></category>
		<category><![CDATA[homeostasis]]></category>
		<category><![CDATA[liver]]></category>
		<category><![CDATA[type 2 diabetes mellitus]]></category>

		<guid isPermaLink="false">http://pharmtao.com/blog5/?p=114</guid>
		<description><![CDATA[<p>AQP9 (aquaporin 9)</p>
<p>[HsT17287, SSC1]</p>
<p>Glycerol production and its efflux from adipocytes to the liver are crucial to modulate lipid and glucose homeostasis. Aquaporin 7 (AQP7) is an aquaglyceroporin functioning as the adipose glycerol channel. Aquaporin 9 (AQP9) is the specific channel operating in the liver. AQP7 and AQP9 mediate the trafficking of glycerol from adipose and [...]]]></description>
		<wfw:commentRss>http://pharmtao.com/blog5/2010/03/25/diseases-obesity-aqp9-aquaporin-9/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.622 seconds -->
